GLEEVEC in Medical News

Prescription Copay Assistance for Patients taking Gleevec or Tasigna for Philadelphia chromosome-positive Chronic Myelogenous Leukemia (Ph+ CML)

Novartis Pharmaceuticals Corporation offers a prescription copay assistance program for Ph+ CML (Chronic Myelogenous Leukemia or Chronic Myeloid Leukemia) patients through the My CML Circle Copay Assistance Program ( www.mycmlcircle.com ). East Hanover, NJ (PRWEB) Febru...

Cancer Drug Gleevec Could Fight Stroke

It might extend the effectiveness of clot-busting tPA, researchers say MONDAY, June 23 (HealthDay News) -- A powerful weapon against cancer might also boost stroke patients' survival, new research suggests. Gleevec, long hailed as a "wonder drug" against cancers such as chronic myel...

Cancer Drug Gleevec Linked to Muscle Damage

French researchers say the problem can probably strike small percentage of patients WEDNESDAY, June 18 (HealthDay News) -- French doctors have reported a possible new side effect associated with the cancer drug Gleevec (imatinib), widely used for the treatment of chronic myeloid leukem...

Protein predicts Gleevec resistance in gastrointestinal tumors

Excess amounts of a protein called IGF-1R in patients with gastrointestinal stromal tumors (GISTs) could indicate that the patient would be less responsive to the drug imatinib mesylate (known as Gleevec), according to Andrew K. Godwin, Ph.D., a researcher at the Fox Chase Cancer Center in Philade...

Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors

The US-based National Cancer Institute (NCI) has commended Novartis' anti-cancer tablet, Gleevec, as an// effective therapy for patients suffering from GISTs, metastatic gastro-intestinal tumors. These tumours do have a rather complicated name. They are found in the digestive system - the g...

"Miracle" Cancer Drug Gleevec Can be Toxic to the Heart

Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart.// Not only that, but other similarly based drugs – called tyrosine kinase inhibitors – could lead to heart problems as well, say researchers a...

The vulnerable cancer cell

...ication of the two kinases as validation of the approaches taken by Elledge and Gilliland. With the dramatic clinical success of cancer drugs, such as gleevec and dasatinib, which target rogue kinases, Sawyers says any screen that turns up new kinases is worthy of further investigation. "The new mantra, q...

Gleevec Prevents Return of Intestinal Cancer, Study Confirms

... THURSDAY, March 19 (HealthDay News) -- Taking gleevec after surgery to remove a gastrointestinal stromal...randomly selected to take either 400 milligrams of gleevec or a placebo once a day for a year after surgery t...up of almost 20 months, 8 percent of people in the gleevec group and 20 percent of those in the placebo group...

Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports

...ival was 98% for Kit-positive GIST patients taking gleevec vs. 83% for patients taking placebo(1) - Hist...hin a median of two years after surgery(3) - gleevec is the only treatment in the US and Switzerland in... an upcoming print issue of The Lancet show that gleevec (R) (imatinib mesylate) tablets*, when taken afte...

Stem cells: Deathly awakening by interferon

...ncer called chronic myelogenous leukemia who are treated with a drug called gleevec almost always relapse after drug treatment has ended. Several patients were given interferon-alpha prior to the gleevec treatment. Surprisingly, these patients experienced long relapse-free phase...

Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009

...ment, PDPs in 2009 are increasing their use of prior authorization to control access to branded cancer drugs. The Avalere-ACS CAN research found that gleevec had the largest increase in the number of PDPs requiring prior authorization, with 70 percent of plans requiring it, up from 35 percent in 2006. Tarce...

Cancer Drugs May Treat Type 1 Diabetes

... Experiments in mice show gleevec and Sutent reverse, prevent autoimmune disease ...port. In experiments with mice, they found that gleevec and a similar cancer drug, Sutent, could prevent t...ulin. "Although targeted to the Bcr-Abl kinase, gleevec has been shown to affect related kinases including...

Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis

...re prone to develop neurofibromas, the cancer drug gleevec an inhibitor of c-kit reduced the metabolic activity and size of the tumors. Because gleevec is already prescribed for chronic myelogenous leuk... researchers also discuss the compassionate use of gleevec in one young neurofibromatosis patient with an air...

Cancer requires support from immune system to develop, UT Southwestern researchers report

... Positron emission tomography scans showed that gleevec halved the metabolic activity of the tumors, while...ause too many blood vessels were involved. Because gleevec is already approved for other conditions, the girl... the long-term effectiveness of the treatment, and gleevec might be exerting other actions in addition to inh...

MicroRNA controls expression of oncogenes

...onic leukemias," concludes Dr. Malumbres. "This may be particularly beneficial for patients who are resistant to small molecule kinase inhibitors like gleevec as resistant isoforms of ABL and BCR-ABL should contain the target site for miR-203 and are likely to respond to restored miR-203 function." ...

Researchers find roadmap to next-generation cancer therapies

...ow our findings may lead to successful targeting of various cancer types and cancer stem cells, he said. Targeted cancer therapy such as the drug gleevec that works for patients with certain types of leukemia and gastrointestinal tumors is based on a keen understanding of the architecture of cancer. Mu...

Arsenic-based therapy shown to help eradicate leukemia-initiating cells

...matinib (Gleevec), a tyrosine kinase inhibitor. gleevec does dramatically improve prognosis of CML patients, notes Pandolfi. But, unfortunately, gleevec is not curative in most cases. Because it targets ... LICs are able to remain intact. As a result, when gleevec therapy is discontinued, the cancer almost inevita...

Immune system pathway identified to fight allergens, asthma

...-6 has been associated with cancers such as multiple myeloma, said Dr. Anuradha Ray. Collectively, similar approaches to inhibit c-Kit, in addition to gleevec or other inhibiting compounds could alleviate multiple cancers. ...

Gleevec Pushes Advanced Melanoma Into Remission

... Woman's case first showing the cancer may have an Achilles' heel, report suggests THURSDAY, April 17 (HealthDay News) -- The cancer drug gleevec has forced metastatic melanoma into remission for the first time, report researchers at the Dana-Farber Cancer Institute in Boston. The case involv...

New Drug Duo Helps Cut Colon Cancer Risk

...isk of metastases in patients with hepatocellular liver cancer, researchers report. Sutent, a member of a family of cancer drugs that also includes gleevec (imatinib), has proven effective against kidney cancer and a type of malignancy called gastrointestinal stromal tumors. Recent studies have also linke...

New Drug Duo Helps Fight Colon Cancer

...isk of metastases in patients with hepatocellular liver cancer, researchers report. Sutent, a member of a family of cancer drugs that also includes gleevec (imatinib), has proven effective against kidney cancer and a type of malignancy called gastrointestinal stromal tumors. Recent studies have also linke...

New Treatments Help Fight Liver, Colon Cancer

...isk of metastases in patients with hepatocellular liver cancer, researchers report. Sutent, a member of a family of cancer drugs that also includes gleevec (imatinib), has proven effective against kidney cancer and a type of malignancy called gastrointestinal stromal tumors. Recent studies have also linke...

OHSU Cancer Institute researchers identify new approach to help control drug resistance in leukemia

..., M.D., is the current first line therapy for CML. gleevec works by inhibiting the activity of Bcr-Abl, an en...ls carry a mutated form of Bcr-Abl, which prevents gleevec from functioning properly. The second-generation d...e on its own. The effectiveness and safety of gleevec for most patients remains remarkable, said Deining...

Gleevec May Disrupt Ovarian Function

...iety. She was initially given 400 milligrams of gleevec daily. About one year into her treatment, the dose of gleevec was increased to 600 milligrams per day, because s...While it's not possible to definitively prove that gleevec caused premature menopause, Christopoulos said tha...

New drug candidate knocks out resistant form of chronic myeloid leukemia

... clinical CML drugs, we may have the therapeutic tools to achieve and maintain even more effective and longer control of their disease, Bumm said. gleevec continues to be remarkably successful in the vast majority of patients. However, for those patients who develop resistance, incorporating a targeted T...

Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment

...m the second year of treatment; no patients taking gleevec in sixth year progressed from initial ...l six-year survival rate for patients treated with gleevec was 88%. Lead investigators presented the latest...hase of CML who received continuous treatment with gleevec did not progress to advanced stages of the disease...

Gleevec, the targeted cancer pill, delivers more good news to patients

...t this weekends meeting continues to show how much gleevec has completely changed the outlook for so many, ma...iety of Hematology researchers delivered news that gleevec has been shown to improve outcomes for children wi...e Childrens Oncology Group study shows that adding gleevec to the treatment almost completely reverses this p...

Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies

...arget the Bcr-Abl protein more preferentially than gleevec without adding new targets. At six months follow-u...is)(2). Recent landmark clinical trial results for gleevec show that nearly 90% of newly diagnosed chronic-phase Ph+ CML adult patients treated with gleevec were alive after five years(3), but some develop r...

Combination therapy reverses effects of portal hypertension in rats

... A combined treatment with rapamycin and gleevec might reverse the effects of portal hypertension in patients with chronic l...treated portal vein-ligated rats with rapamycin (VEGF signaling inhibitor), gleevec (PDGF signaling inhibitor) or both simultaneously, and determined the effec...

Genetics Hold Promise, Challenges for Cancer Care

...Dr. Len Lichtenfeld, deputy chief medical officer at the American Cancer Society. While gene-specific treatments such as the leukemia "wonder drug" gleevec are already on the scene, "we still have an incredibly long way to go in terms of how we understand the basic genetics of cancer," he said. "Right ...

Study suggests brain tumors need treatment with multiple 'targeted' drugs

...eptor tyrosine kinases (RTKs) that often are mutated and hyperactive in cancer cells. Since a number of kinase-blocking drugs are already available -- gleevec and Tarceva are two of the best-known -- the researchers said clinical trials of combinations of the compounds should be planned quickly. "This is ...

A New Two-gene Test to Discern Similar Gastrointestinal Cancers

...nal tract. However, GIST is treatable with the targeted medication known as gleevec and is relatively unresponsive to chemotherapy. The opposite is true of LMS...tegy to identify gene pairs that can predict which GIST patients respond to gleevec and how other types of cancer respond to treatment as well. Source-Eure...

Drop Patent Petition, Activists Ask Novartis

...eveloping countries. A patent grant to Novartis on gleevec will certainly make cancer medicine unaffordable f... cancer costs Rs.8,000 for one month of treatment, gleevec costs Rs.120,000. If Novartis gets the patent, the...w. The company's application for a patent on gleevec was opposed by the CPAA and subsequently rejected ...

A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers

...sk of death. Perner says investigators are hoping to find a small molecule to inhibit the TMPRSS2-ERG fusion protein in the same way that the drug gleevec has revolutionized care of CML. Prediagnostic interleukin-6, C-reactive protein and prostate cancer incidence and mortality Increased levels of t...

Three Molecular Triggers Threaten Leukemia Patients

...plants. One of the great successes of cancer treatment has been development of targeted therapy for chronic myelogenous leukemia (CML). The drug gleevec and its successors inhibit one aberrant protein, increasing the median 5-year survival of CML patients from 50 percent to 90 percent. For AML, that ap...

New Technique Identifies Unknown Genetic Mutations That Can Cause Cancer

...inases are already on the market, including Gleevec, which Druker pioneered for treatment of chronic myelogenous leukemia. Since its approval in 2001, gleevec has made CML a much more manageable disease. A new drug to inhibit JAK3 is already in development elsewhere, and, eventually; Druker sees a mark...

A New Anti-Cancer Drug Keeps Resistance Out

...ents than the usual drug named Gleevec. Patients, who are resistant to gleevec drug can now be treated with dasatinib, which seems to regulate intolerance...lished in NEJM finds. In the phase I clinical trials dasatinib overcome gleevec resistance in about 68 of 84 patients studied - study leader, HHMI investig...

PI-103 Effective against Brain Cancer

...27. Food and Drug Administration approval five years ago of the cancer drug gleevec marked a promising new strategy against cancer. gleevec was the first drug on the market designed to block ubiquitous signaling mol...

Molecular Flaw Detected in Aggressive Breast Cancers

...which triggers CDK4 kinase. This is a "growth switch", which unleashes a virulent proliferation of cancer cells. "The development of cancer drugs like gleevec and Iressa have shown that it is possible to block the action of kinases," said Sicinski, "so we hope that these findings will stimulate interest in d...

War Against Cancer Continues

... are also reported to be responsible for stomach cancer. The intensive cancer research has resulted in the survival rate rising to 64%. New drugs like gleevec and Herceptin have also contributed towards this. The suffering and death due to cancer is sought to be eliminated by 2015 by the National Cancer Inst...